InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Robinson Chandler, Chief Executive Officer. Director active across 1 companies, notably Monopar Therapeutics. In total, 10 disclosures have been recorded. Regulator: SEC (Form 4). All data is free.
Declarations10 total
23,882 shares
Common Stock
SEC:0001654954-22-009138:0·
3,941 shares
Common Stock
SEC:0001654954-22-004491:0·
6,724 shares
Common Stock
SEC:0001654954-22-000126·
3,941 shares
Common Stock
SEC:0001654954-22-000124·
6,724 shares
Common Stock
SEC:0001654954-22-000126:0·
3,941 shares
Common Stock
SEC:0001654954-22-000124:0·
3,941 shares
Common Stock
SEC:0001654954-21-010715·
3,941 shares
Common Stock
SEC:0001654954-21-010715:0·
7,883 shares
Common Stock
SEC:0001654954-21-007593·
7,883 shares
Common Stock
SEC:0001654954-21-007593:0·
10 of 10 declarations
About Robinson Chandler
Chandler Robinson is the Chief Executive Officer at Monopar Therapeutics. He is responsible for the overall management of the company and the implementation of strategies. His role involves overseeing operations and ensuring compliance with regulations. With his expertise, he contributes to the overall performance of the company.
